Prelude Capital Management, LLC Sangamo Therapeutics, Inc Transaction History

Prelude Capital Management, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 15, 2020	SELL	$5.05 - $8.85 $1,393 - $2,442	-276 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$8.03 - $11.7 $385 - $561	-48 Reduced 14.81%	276 $2,000
Q3 2019 Nov 14, 2019	SELL	$9.05 - $12.22 $352 - $476	-39 Reduced 10.74%	324 $3,000
Q2 2019 Aug 14, 2019	SELL	$8.75 - $13.03 $3,718 - $5,537	-425 Reduced 53.93%	363 $4,000
Q1 2019 May 15, 2019	BUY	$7.72 - $12.81 $6,083 - $10,094	788 New	788 $8,000
Q4 2018 Feb 14, 2019	SELL	$9.51 - $16.6 $406,638 - $709,799	-42,759 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$13.9 - $19.8 $591,319 - $842,311	42,541 Added 19514.22%	42,759 $607,000
Q1 2018 May 15, 2018	SELL	$16.7 - $26.35 $6,179 - $9,749	-370 Reduced 62.93%	218 $4,000
Q4 2017 Feb 14, 2018	SELL	$11.6 - $17.35 $8,839 - $13,220	-762 Reduced 56.44%	588 $10,000
Q3 2017 Nov 14, 2017	BUY	$8.4 - $15.0 $11,340 - $20,250	1,350	1,350 $20,000

133

86.3M

35.9K

156K

Ticker SGMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 156,552,992
Market Cap $132M
Description
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Prelude Capital Management, LLC with notifications on news.